Unveiling the Gut's Vulnerability: Ebola and Marburg Viruses Target Human Intestinal Cells
The deadly Ebola (EBOV) and Marburg viruses have long been known for their devastating impact on the human body, but a recent study reveals a surprising target: the gut. These viruses, notorious for causing severe illness and extensive bodily damage, also wreak havoc on the gastrointestinal tract, leading to life-threatening diarrhea and dehydration. The study, led by Elizabeth Yvonne Flores, PhD, and her team, delves into the mechanisms behind this gut damage, shedding light on the role of intestinal cells in these deadly infections.
The research, published in PLOS Pathogens, uncovers a critical aspect of filovirus infections. It demonstrates that both EBOV and MARV can infect and replicate within human gut epithelial cells, disrupting their normal function. The viruses interfere with the cells' ability to regulate fluid secretion, mirroring the severe symptoms observed in patients. This discovery is a significant step forward in understanding the complex relationship between these viruses and the human body.
"This research not only enhances our understanding of how filovirus infections damage the gut but also identifies potential cellular pathways for targeted treatments," explains Elke Mühlberger, PhD, a professor of virology, immunology, and microbiology. "It highlights the value of using iPSC-derived organoids to study viral diseases."
To study the human gut in a controlled environment, the researchers created organoids, miniature 3D structures that mimic human intestinal and colonic tissue. These organoids, derived from induced pluripotent stem cells (iPSCs), were successfully infected with EBOV and MARV, allowing the team to observe the viruses' replication within the tissue. By analyzing gene activity signatures, they discovered that the small intestine and colon organoids responded differently, with more severe dysfunction in the colonic organoids.
The infections disrupted key signaling pathways involved in ion and fluid transport in the gut, damaging the gut lining's structure. This damage included the apical and junctional components that control what passes through the intestinal wall, potentially explaining the massive fluid loss leading to life-threatening diarrhea. Interestingly, the infected mini-guts showed a delayed innate immune response, specifically in the production of interferon-stimulated genes, which usually help fight off viruses.
"The organoid platform successfully captures key features of human GI pathology, making it a powerful tool for future research to understand host-pathogen interactions better and identify potential therapeutic targets to treat these deadly diseases," said Gustavo Mostoslavsky, MD, PhD, a professor of medicine and virology, immunology, and microbiology. This study not only advances our understanding of filovirus infections but also opens new avenues for developing targeted treatments and improving patient outcomes.
